P/E ratio for Monash IVF Group (MVF.AX)
P/E ratio at the end of 2023: 19.1
According to Monash IVF Group's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 18.9373. At the end of 2023 the company had a P/E ratio of 19.1.
P/E ratio history for Monash IVF Group from 2014 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2023 | 19.1 | 2.23% |
| 2022 | 18.7 | 72.6% |
| 2021 | 10.8 | 1.62% |
| 2020 | 10.6 | -29.2% |
| 2019 | 15.0 | 49.11% |
| 2018 | 10.1 | -14.7% |
| 2017 | 11.8 | -6.14% |
| 2016 | 12.6 | 9.58% |
| 2015 | 11.5 | -80.83% |
| 2014 | 59.9 |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.